warrant

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of 15 million

Provides immediate new financing to support the Company’s next strategic milestones Strengthens shareholders’ equity and improves the Company’s financial structure…

1 month ago

Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program

November 28, 2025 20:13 ET  | Source: Rakovina Therapeutics Inc VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina…

7 months ago

Enovix Announces Completion of Warrant Dividend Program

September 05, 2025 18:08 ET  | Source: Enovix Corporation Warrants Expired and Ceased Trading on Friday, August 29, 2025 Approximately…

10 months ago

Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date

August 28, 2025 17:55 ET  | Source: Enovix Corporation Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025…

10 months ago

Enovix Shareholder Second Reminder: Early Warrant Expiration Price Condition

Enovix Warrants: 14 of 14 Trading Days Above $10.50 August 08, 2025 18:57 ET  | Source: Enovix Corporation FREMONT, Calif.,…

11 months ago

Enovix Shareholder Reminder: Early Warrant Expiration Price Condition

Enovix Warrants: 9 of 9 Trading Days Above $10.50 August 01, 2025 16:59 ET  | Source: Enovix Corporation FREMONT, Calif.,…

11 months ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement…

12 months ago

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

June 16, 2025 19:20 ET  | Source: PolyPid Ltd. The Company Anticipates that with this Additional Funding, PolyPid’s Runway would…

1 year ago